In a webinar with U.S. News & World Report, Dr. Anthony Chang discusses how the COVID-19 pandemic propelled medical innovation at CHOC.
Medical device research leads to improved neonatal care
A partnership between CHOC and Masimo has developed technology to noninvasively monitor blood oxygen and hemoglobin levels in newborns.
Innovative protocol studies treatment for rare pediatric PTCL and NK/T-Cell lymphoma
CHOC helps develop innovative treatment protocols for PTCL and NK/T-cell lymphoma, which are now available for patients.
Rare disease leaders to speak at inaugural symposium and family conference on March 11
The Inaugural CHOC and UCI Rare Disease Symposium & Family Conference will take place on Friday, March 11, 2022, from 10:30 a.m. to 3 p.m.
Dog bite study shows youngest kids most at risk, which breeds inflict the most severe injuries
This study is one of the first to stratify injury severity based on the type of surgical treatment required.
Neurologist to lead first-ever study of kids with Down syndrome to assess their likelihood of developing Alzheimer’s disease in adulthood
The study will examine biochemical markers in the blood of children with Down syndrome for a likelihood of them developing Alzheimer’s disease in adulthood.
